Seer (SEER) Change in Account Payables (2020 - 2026)
Seer (SEER) posted quarterly Change in Account Payables of -$3.0 million for Q1 2026, down 27218.18% year-over-year from N/an in Q1 2025, and down 338.11% quarter-over-quarter from $1.3 million in Q4 2025.
Seer (SEER) Change in Account Payables (2020 - 2026) Analysis & Trends
Seer's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 27218.18% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$1.9 million (down 198.42% YoY), while the FY2025 annual figure was $1.1 million, down 68.35% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$3.0 million, down from $1.3 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.7 million in Q4 2024, with the low at -$3.7 million in Q3 2024.
- The 5-year median for Change in Account Payables is -$11000.0 (2025), against an average of -$66352.9.
- The sharpest annual moves came in 2024 and 2026: Change in Account Payables soared 203300.0% in 2024, then slumped 27218.18% in 2026.
- Seer's Change in Account Payables stood at -$1.1 million in 2022, then surged by 132.97% to $366000.0 in 2023, then jumped by 906.01% to $3.7 million in 2024, then tumbled by 65.73% to $1.3 million in 2025, then sank by 338.11% to -$3.0 million in 2026.
- Business Quant data shows SEER's Change in Account Payables at -$3.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 379,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 379,000.00 |
| Jun 30, 2026 | 379,000.00 |
| Mar 31, 2026 | -3.01 Mn |
| Mar 31, 2026 | -3.01 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -11,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | 3.68 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | -3.74 Mn |
| Sep 30, 2024 | -3.74 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.38 Mn |